These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7152857)

  • 1. Computerized tomographic (CT) appearance of the myocardium after reversible and irreversible ischemic injury.
    Newell JD; Mayr W; Gerber KH; Higgins CB
    Invest Radiol; 1982; 17(6):544-9. PubMed ID: 7152857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of iodinated contrast material in the evaluation of myocardial infarction by computerized transmission tomography.
    Higgins CB; Siemers PT; Newell JD; Schmidt W
    Invest Radiol; 1980; 15(6 Suppl):S176-82. PubMed ID: 7203920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiation of reversible and irreversible myocardial injury by MR imaging with and without gadolinium-DTPA.
    McNamara MT; Tscholakoff D; Revel D; Soulen R; Schechtmann N; Botvinick E; Higgins CB
    Radiology; 1986 Mar; 158(3):765-9. PubMed ID: 3945751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of myocardial ischemic damage of various ages by computerized transmission tomography. Time-dependent effects of contrast material.
    Higgins CB; Siemers PT; Schmidt W; Newell JD
    Circulation; 1979 Aug; 60(2):284-91. PubMed ID: 445746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of computerized tomography to assess myocardial infarct size and ventricular function in dogs during acute coronary occlusion and reperfusion.
    Mancini GB; Peck WW; Slutksy RA; Ross J; Higgins CB
    Am J Cardiol; 1984 Jan; 53(2):282-9. PubMed ID: 6229993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatty acid analogue accumulation: a marker of myocyte viability in ischemic-reperfused myocardium.
    Miller DD; Gill JB; Livni E; Elmaleh DR; Aretz T; Boucher CA; Strauss HW
    Circ Res; 1988 Oct; 63(4):681-92. PubMed ID: 3048774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coronary cyclic flow variations "precondition" ischemic myocardium.
    Ovize M; Kloner RA; Hale SL; Przyklenk K
    Circulation; 1992 Feb; 85(2):779-89. PubMed ID: 1735170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantification of area at risk during coronary occlusion and degree of myocardial salvage after reperfusion with technetium-99m methoxyisobutyl isonitrile.
    Sinusas AJ; Trautman KA; Bergin JD; Watson DD; Ruiz M; Smith WH; Beller GA
    Circulation; 1990 Oct; 82(4):1424-37. PubMed ID: 2401074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of drug intervention on the ischemic myocardium: serial imaging and measurement with computerized tomography.
    Powell WJ; Wittenberg J; Miller SW; Maturi RA; Dinsmore RE
    Am J Cardiol; 1979 Jul; 44(1):46-52. PubMed ID: 453045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal myocardial fluid retention as an early manifestation of ischemic injury.
    Willerson JT; Scales F; Mukherjee A; Platt M; Templeton GH; Fink GS; Buja LM
    Am J Pathol; 1977 Apr; 87(1):159-88. PubMed ID: 139829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regional differences in postischemic recovery in the stunned canine myocardium.
    Farber NE; Pieper GM; Gross GJ
    Am Heart J; 1987 Nov; 114(5):1086-95. PubMed ID: 3673875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The "wavefront phenomenon" of myocardial ischemic cell death. II. Transmural progression of necrosis within the framework of ischemic bed size (myocardium at risk) and collateral flow.
    Reimer KA; Jennings RB
    Lab Invest; 1979 Jun; 40(6):633-44. PubMed ID: 449273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myocardial neutrophil accumulation during reperfusion after reversible or irreversible ischemic injury.
    Go LO; Murry CE; Richard VJ; Weischedel GR; Jennings RB; Reimer KA
    Am J Physiol; 1988 Nov; 255(5 Pt 2):H1188-98. PubMed ID: 2461099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional ischemic 'preconditioning' protects remote virgin myocardium from subsequent sustained coronary occlusion.
    Przyklenk K; Bauer B; Ovize M; Kloner RA; Whittaker P
    Circulation; 1993 Mar; 87(3):893-9. PubMed ID: 7680290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of repetitive brief episodes of ischemia on cell volume, electrolytes and ultrastructure.
    Basuk WL; Reimer KA; Jennings RB
    J Am Coll Cardiol; 1986 Jul; 8(1 Suppl A):33A-41A. PubMed ID: 3711542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preconditioning does not attenuate myocardial stunning.
    Ovize M; Przyklenk K; Hale SL; Kloner RA
    Circulation; 1992 Jun; 85(6):2247-54. PubMed ID: 1591839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reperfusion of ischemic myocardium: ultrastructural and histochemical aspects.
    Schaper J; Schaper W
    J Am Coll Cardiol; 1983 Apr; 1(4):1037-46. PubMed ID: 6833643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myocardial infarct size determined by computed transmission tomography in canine infarcts of various ages and in the presence of coronary reperfusion.
    Slutsky RA; Peck WW; Mancini GB; Mattrey RF; Higgins CB
    J Am Coll Cardiol; 1984 Jan; 3(1):138-42. PubMed ID: 6361100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Verapamil in two reperfusion models of myocardial infarction. Temporary protection of severely ischemic myocardium without limitation of ultimate infarct size.
    Reimer KA; Jennings RB
    Lab Invest; 1984 Dec; 51(6):655-66. PubMed ID: 6503220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathobiology of acute myocardial ischemia: metabolic, functional and ultrastructural studies.
    Reimer KA; Jennings RB; Tatum AH
    Am J Cardiol; 1983 Jul; 52(2):72A-81A. PubMed ID: 6869259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.